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Changes, destructions and interruptions in middle ear 
ossicular chain architecture may be caused by infection, 
trauma, tumors, congenital alterations or prior surgeries. 
Nonetheless, infectious and inflammatory processes, focal 
or generalized which affect the middle ear are the most 
prevalent, causing a great demand for ossiculoplasty. 
Biosilicato® is a new material which can be used in the 
middle ear with the goal of reconstructing the ossicular chain. 
It is a bioactive type A vitroceramic, in other words, it binds 
to bone or soft tissue in a matter of a few hours, thanks to the 
formation of hydroxy-carbonateapatatie in its contact surface 
when in contact with body fluids. Aims: The goal of the 
present paper is to assess biosilicate ototoxicity and vestibular 
toxicity in experimental animals, for later use in humans. 
Materials and Methods: This a clinical and experimental 
study in which otoacoustic emissions were performed before 
and after the placement of Biosilicate in the middle ear of 
experimental animals and a scanning electron microscopy 
was carried out in the cochlea, saccule, utriculus and macula 
of the semicircular canals after 30 and 90 days to assess oto 
and vestibular toxicity. Results: There were no signs of oto 
or vestibular toxicity in any of the groups associated with 
biosilicate. Conclusion: Biosilicate is a safe material to be 
used in ossiculoplasties
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INTRODUCTION
Changes, destructions and interruptions in the mi-
ddle ear ossicular chain in humans may be of infectious 
origin, trauma, tumor, congenital or due to prior surgery. 
Nonetheless, infectious inflammatory processes1, focal 
or generalized which affect the middle ear are the most 
prevalent. This disease is defined as otitis media.
Otitis media affects 2% of the population, and 8% 
of school age children. It affects millions of persons every 
year, generating huge financial costs2.
Thus, if we analyze only the number of chronic 
otitis media and its many variations: cholesteatoma, cho-
lesterol granuloma, adhesive otitis, granulomatous otitis, 
the percentage of people who may require surgical inter-
vention to correct ossicles defects is enormous. Surgeries 
for the reconstruction of the ossicular chain are called 
ossiculoplasties. The first reconstructions were made by 
Wullstein in 19563.
Different materials are used in ossiculoplasties, all 
with good results4, which according to their own nature 
and origin are called autografts, homografts and synthetic 
prosthesis5.
The autografts6 are the remains of the ossicles, cra-
nial cortical bones7 and cartilage of the patient8.
The homologous grafts are ossicles obtained from 
banks of organ donation; however, they are no longer 
used because of AIDS. 
Synthetic materials are the ones most used. Among 
them we have titanium prosthesis9-11, ceramic12,13, hydro-
xiapatite14,15, plastipore16, and bone cement17.
Biosilicate® is a new material which can be used in 
middle ears with the goal of reconstructing the ossicular 
chain. It is type A bioactive vitroceramic, it binds to the 
bone tissue or soft tissue in a few hours, because hydro-
xyapatite forms on its contact surface when in contact 
with body fluids18.
The goal of the present study was to assess biosili-
cate ototoxicity and vestibulotoxicity in laboratory animals, 
for later use in humans.
MATERIALS AND METHODS
According to approval by the Ethics Committee 
under protocol # 046/2005, we used 15 albino male lab 
animals weighing between 400g to 600g, with Preyer’s re-
flex present and Distortion Product Otoacoustic Emissions 
(ILO 92 CAE System otodynamics LTD equipment) present 
in both sides. These otoemissions were measured in the 
pre and postoperative (before the animals were slaughte-
red) without sedation, and then the animals were broken 
down into 3 groups of 5 animals in each.
These animals were anesthetized with intraperito-
neal pentobarbital 40mg/kg and injected with penicillin; 
immediately after we injected the retroauricular region with 
2% xylocaine associated to adrenalin 1:200.000 bilaterally. 
A 1cm retroauricular incision was made all the way to the 
bulla, causing bilateral exposure; a bone window was open 
under microscopic view (DF Vasconcellos Microscope) to 
access the middle ear.
In groups 1 and 2 we used powder Biosilicate® 
(Fig. 1), closing the bulla with bone cement in a total of 
10 lab animals. In Group 3 (control) the bulla was opened 
and closed immediately after opening with dental cement.
In Group 1, the animals were slaughtered 30 days 
later and in Group 2 and 3 they were slaughtered 90 days 
after the surgical procedure. Their cochleas, saccule, utri-
cle and vestibular ampullae were removed for scanning 
electron microscopy (SEM).
Figure 1. Lab animal cochlea with powder otosilicate around the 
cochlea and round window.
The animals were slaughtered in a scheduled 
fashion under anesthesia by ether, and they were later 
beheaded in order to remove the cochlea from their bullas. 
With microscopic dissection the cochleas were 
soaked in a fixation solution of 3% Glutaraldehyde at 
4º Celsius and kept in solution for 24 hours for fixation 
purposes. The steps that followed were carried out at the 
Electron Microscopy Lab of the Molecular and Cellular 
Biology and Pathogenic Bioagents Department.
The 3% glutaraldehyde solution in 0.1M, pH = 7.4 
phosphate buffer was injected in the cochleas through the 
round window for 4 hours at 4º Celsius, flushed three times 
for 5 minutes with the same buffer solution, afterwards 
they were fixed with 1% osmium tetroxide for 2 hours 
at 4º Celsius and were submitted to dehydration at room 
temperature and in an increasing battery of ethanol (50%, 
70%, 90% and 95% - once, for 10 minutes in each concen-
tration) and absolute ethanol three times for 15 minutes. 
After dehydration, it was dried by the CO
2
 critical point 
method, when the water was taken off the material. After 
being fixed in a proper specimen holder, the material 
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was coated with gold vapors in a vacuum chamber and 
examined under SEM (Jeol JSM 5200 microscope).
After photographed, the results obtained from the 
SEM were analyzed through cochleograms. We counted 
the number of outer hair cells on the cochlear basal turn 
in a certain photographic fields and we counted 10 cells, 
present or absent.
The saccular and utricle maculae, as well as the am-
pullae of the semi-circular canals were prepared the same 
way as the cochlea and assembled on a separate specimen 
holder. We established that the damage to the vestibular 
neuroepithelium would be based on the disappearance 
or rarefaction of the stereocilia bundles of the vestibular 
hair cells assessed by SEM.
Figure 2. Cochlea basal ramp belonging to an animal from the oto-
silicate group after 30 days, where we can see all the external and 
internal hair cells.
Figure 3. Cochlea basal ramp belonging to an animal from the oto-
silicate group after 90 days. Inner and outer hair cells without lesion.
Figure 4. Crest of the lateral canal ampulla without alteration. Otosili-
cate group - 30 days.
Figure 5. Saccular macula of the otosilicate group - 90 days, without 
lesion.
RESULTS
All the 5 lab animals (10 ears) which were slaughte-
red within 30 days presented inner and external hair cells 
preserved without any sign of ototoxicity (Fig. 2) when 
assessed by SEM. We carried out the Fisher’s exact test 
(p≤0.05 significance level) with a p=1 result, indicating no 
ototoxicity in the otosilicate group, statistically significant.
The laboratory animals which were slaughtered 
within 90 days had otosilicate in Group 2, and only bulla 
cover in Group 3 (5 animals in each group), making up 
a total of 20 ears, did not show signs of ototoxicity (Fig. 
3). Through the Fisher’s exact test, p=1, there was no 
ototoxicity in groups 2 and 3, with statistical significance.
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We did not observe signs of vestibulotoxicity in 
the animals tested within 30 and 90 days of exposure to 
otosilicate (p>0.05). (Figs. 4 and 5)
DISCUSSION
Different animal models were tested in order to 
assess the ototoxicity of biocompatible materials for use as 
prosthesis in the middle ear such as rats19, mice20, guinea 
pigs21, rabbits1, cats22. Zikk et al.21 utilized ceravital grains, 
not observing hearing loss measured by the brainstem 
evoked auditory potential in 100% of the animals.
The otosilicate (biosilicate®) proved not ototoxic or 
vestibulotoxic for the guinea pigs tested, there was no des-
truction of inner or outer hair cells within 30 and 90 days 
of exposure, proving to be a material of good tolerability 
and compatibility as already shown in other studies18. In the 
study by Moura (2007) they also observed the formation 
of hydroxycarbonate apatite on the otosilicate surface after 
24 hours, in cell culture liquid, showing its high bioactivity 
(class A). With this accelerated in vitro osteogenesis, there 
is a lower likelihood of extrusion of such material in the 
postoperative of ossiculoplasties.
Thus, by approval from the ethics committee of 
experimentation in humans, we started to use this mate-
rial as middle ear prosthesis in humans, partial prosthesis 
- when we have the stapes or total prosthesis when we 
place the prosthesis directly on the stapes footplate. We 
started the surgical procedures in humans, expecting to be 
successful on the first results obtained; however, because 
of the reduced number of cases and the restricted follow 
up time, this study must be expanded.
CONCLUSION
Otosilicate (biosilicate®) did not present ototoxicity 
or vestibulotoxicity for the lab animals studied, proving to 
be a safe and promising material to be used as a prosthesis 
for ossicular reconstruction in humans.
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